Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Cited by (1,041)

Items 901–1,000 of 1,041

1. Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8+ T cell response and better prognosis in HBV-related hepatocellular carcinoma
   Rong, Yihui, Dong, Zheng, Hong, Zhixian, Jin, Yun, Zhang, Wei, Zhang, Bailong, Mao, Wei, Kong, Huifang, Wang, Chunping, Yang, Bin et al. · 2017 · Experimental Cell Research
2. Biomarkers for Immune Checkpoint Inhibitors in Melanoma
   Shigehisa Kitano, Takayuki Nakayama, Makiko Yamashita · 2018 · Frontiers in Oncology
3. Microbiota transplantation: Targeting cancer treatment
   Xia Wu, Ting Zhang, Xiong Chen, Guozhong Ji, Faming Zhang · 2019 · Cancer Letters
4. Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors
   Anne Schett, Sacha I. Rothschild, Alessandra Curioni Fontecedro, Stephan Krähenbühl, Martin Früh, Sabine Schmid, Christoph Driessen, Markus Joerger · 2019 · Cancer Chemotherapy and Pharmacology
5. Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions
   Dibyendu Dutta, Seah H. Lim · 2020 · Biomarker Research
6. The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
   Robert Ballotti, Yann Chéli, Corine Bertolotto · 2020 · Molecular Cancer
7. Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12
   Qingxiang Li, Yuke Li, Yifei Wang, Le Xu, Yuxing Guo, Yixiang Wang, Lin Wang, Chuanbin Guo · 2021 · OncoImmunology
8. A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma
   Gouri Pandya, Anuradha Kirtonia, Aishwarya Pratap Singh, Arul Goel, Chakrabhavi Dhananjaya Mohan, Kanchugarakoppal Subbegowda Rangappa, Amit Kumar Pandey, Sonia Kapoor, Simran Tandon, Gautam Sethi et al. · 2021 · Seminars in Cancer Biology
9. Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities
   Davood Bashash, Zahra Zandi, Bahareh Kashani, Atieh Pourbagheri‐Sigaroodi, Sina Salari, Seyed Hamidollah Ghaffari · 2021 · Journal of Cellular Physiology
10. Glioma and the gut–brain axis: opportunities and future perspectives
    Antonio Dono, Jack Nickles, Ana G. Rodriguez-Armendariz, Braden C. McFarland, Nadim J. Ajami, Leomar Y. Ballester, Jennifer Ann Wargo, Yoshua Esquenazi · 2022 · Neuro-Oncology Advances
11. The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment
    Feng Gao, Bo Yu, Benchen Rao, Ying Hao Sun, Jia Yu, Daming Wang, Guangying Cui, Zhigang Ren · 2022 · Frontiers in Immunology
12. Roles of microbiota in response to cancer immunotherapy
    Kentaro Inamura · 2020 · Seminars in Cancer Biology
13. Preventive effect of Lactobacillus reuteri on melanoma
    Meng Luo, Miaomiao Hu, Feng Xu, Xiaoli Wu, Degang Dong, Wanchun Wang · 2020 · Biomedicine & Pharmacotherapy
14. Gut Microbiota and Lung Injury
    Ji-yang Tan, Yichun Tang, Jie Huang · 2020 · Advances in experimental medicine and biology
15. The tumor organismal environment: Role in tumor development and cancer immunotherapy
    Lothar C. Dieterich, Andréas Bikfalvi · 2019 · Seminars in Cancer Biology
16. Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect
    Erez N. Baruch, Jingjing Wang, Jennifer Ann Wargo · 2021 · Cancer Immunology Research
17. Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression
    Valentino Le Noci, Giancarla Bernardo, Francesca Bianchi, Elda Tagliabue, Michele Sommariva, Lucia Sfondrini · 2021 · Frontiers in Cell and Developmental Biology
18. The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy
    Meiqi Wang, Ge Yang, Yuan Tian, Qihe Zhang, Zhuo Liu, Ying Xin · 2023 · Frontiers in Immunology
19. The role of pyroptosis and gasdermin family in tumor progression and immune microenvironment
    Mengyuan Li, Ping Jiang, Yuhan Yang, Liting Xiong, Shuhua Wei, Junjie Wang, Chunxiao Li · 2023 · Experimental Hematology and Oncology
20. Gut microbiome affects the response to immunotherapy in non‐small cell lung cancer
    Shengnan Ren, Lingxin Feng, Haoran Liu, Yuke Mao, Zhuang Yu · 2024 · Thoracic Cancer
21. Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer
    Seul A. Lee, Fang Liu, Stephen M. Riordan, Cheok S. Lee, Li Zhang · 2019 · Frontiers in Oncology
22. Significance of human microbiome in breast cancer: Tale of an invisible and an invincible
    Jatin Chadha, Deeptashree Nandi, Yama Atri, Alo Nag · 2020 · Seminars in Cancer Biology
23. Nutraceuticals in colorectal cancer: A mechanistic approach
    Marco Rossi, Sina Mirbagheri, Ali Keshavarzian, Faraz Bishehsari · 2018 · European Journal of Pharmacology
24. The role of the bacterial microbiome in the treatment of cancer
    Zi‐Kun Yu, Ruiling Xie, Rui You, You‐Ping Liu, Xu-Yin Chen, Ming‐Yuan Chen, Pei-Yu Huang · 2021 · BMC Cancer
25. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer
    Xinxin Hou, Zongmei Zheng, Jiao Wei, Ling Zhao · 2022 · Frontiers in Immunology
26. Intestinal epithelial HDAC3 and MHC class II coordinate microbiota-specific immunity
    Emily M. Eshleman, Tzu‐Yu Shao, Vivienne Woo, Taylor Rice, Laura Engleman, Bailey J. Didriksen, Jordan Whitt, David B Haslam, Sing Sing Way, Theresa Alenghat · 2023 · Journal of Clinical Investigation
27. Immunological nanomaterials to combat cancer metastasis
    Yuanbo Pan, Junjie Cheng, Yang Zhu, Jianmin Zhang, Wenpei Fan, Xiaoyuan Shawn Chen · 2024 · Chemical Society Reviews
28. Gut microbiota and hematopoietic stem cell transplantation: where do we stand?
    Daniele Zama, Elena Biagi, Riccardo Masetti, Paola Gasperini, Arcangelo Prete, Marco Candela, Patrizia Brigidi, Andrea Pession · 2016 · Bone Marrow Transplantation
29. The Molecular Revolution in Cutaneous Biology: Investigating the Skin Microbiome
    Heidi H. Kong, Julia A. Segre · 2017 · Journal of Investigative Dermatology
30. The Role of the Microbiome in Drug Response
    Rosina E. Pryor, Daniel Martínez‐Martínez, Leonor M. Quintaneiro, Filipe Cabreiro · 2019 · The Annual Review of Pharmacology and Toxicology
31. Impact of the Gut Microbiome on Immune Checkpoint Inhibitor Efficacy—A Systematic Review
    Julien Pierrard, Emmanuel Seront · 2019 · Current Oncology
32. A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade
    Ivy X. Chen, Kathleen Newcomer, Kristen E. Pauken, Vikram R. Juneja, Kamila Naxerova, Michelle W. Wu, Matthias Pinter, Debattama R. Sen, Meromit Singer, Arlene H. Sharpe et al. · 2020 · Proceedings of the National Academy of Sciences
33. DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers
    Juan Ruiz Bañobre, Ajay Goel · 2018 · Gastroenterology
34. Gut microbiota: impacts on gastrointestinal cancer immunotherapy
    Harry Cheuk-Hay Lau, Joseph J.�Y. Sung, Jun Qing Yu · 2021 · Gut Microbes
35. Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure
    Jean‐Luc Raoul, Camille Moreau-Bachelard, Marine Gilabert, Julien Edeline, Jean‐Sébastien Frenel · 2023 · ESMO Open
36. Roles of microbiota in pancreatic cancer development and treatment
    Mariana Santos Cruz, Joseph Tintelnot, Nicola Gagliani · 2024 · Gut Microbes
37. The role of bile acid receptor TGR5 in regulating inflammatory signalling
    Daijiao Ye, Jiayao He, Xiaofei He · 2024 · Scandinavian Journal of Immunology
38. Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies
    Shivshankari Rajkumar, Ian R. Watson · 2016 · British Journal of Cancer
39. Immunotherapy in gastrointestinal cancers
    Patrick M. Grierson, Kian‐Huat Lim, Manik A. Amin · 2017 · Journal of Gastrointestinal Oncology
40. Immuno-oncology-101: overview of major concepts and translational perspectives
    Bertrand Allard, Sandrine Aspeslagh, Soizic Garaud, Floriane Dupont, Cinzia Solinas, Marleen Kok, Bertrand Routy, Christos P. Sotiriou, John Stagg, Laurence Buisseret · 2018 · Seminars in Cancer Biology
41. Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
    Xinyu Yan, Shouyue Zhang, Yun Deng, Peiqi Wang, Qianqian Hou, Heng Xu · 2018 · Frontiers in Pharmacology
42. Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression
    Antonio Sica, Valentina Guarneri, Alessandra Gennari · 2019 · Cell Stress
43. Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy
    Jumin Huang, Zebo Jiang, Yuwei Wang, Xiaoqing Fan, Jun Cai, Xiaojun Yao, Liang Liu, Jun Huang, Jianxing He, Chun Xie et al. · 2020 · Current Opinion in Pharmacology
44. Sensor array for rapid pathogens identification fabricated with peptide-conjugated 2D metal-organic framework nanosheets
    Zhaowei Sun, Shuai Wu, Ying Peng, Minghui Wang, Mohammed Jalalah, M.S. Al-Assiri, Farid A. Harraz, Jie An Yang, Genxi Li · 2020 · Chemical Engineering Journal
45. Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma
    Hilary R. Keller, Xin Zhang, Li Li, Helmut Schaider, James W. Wells · 2017 · Oncotarget
46. Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the Microbiome
    Allison Betof Warner, Jennifer Leigh McQuade · 2019 · Current Oncology Reports
47. Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
    Relinde I. Y. Lieverse, Damiënne Marcus, Alexander Marie-Madeleine Adrianus van der Wiel, Evert Jan Van Limbergen, Jan Theys, Ala Yaromina, Philippe Lambin, Ludwig Jerome Dubois · 2020 · Molecular Oncology
48. Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review
    Cheng-Liang Huang, Meizhang Li, Ben Liu, Huanbo Zhu, Qun Dai, Xianming Fan, Kathan Dilipbhai Mehta, Chao Hui Huang, Prakash C. Neupane, Fen Wang et al. · 2021 · Frontiers in Oncology
49. The relationship between gastrointestinal cancers and the microbiota
    Kaitlyn D. LaCourse, Christopher D. Johnston, Susan Bullman · 2021 · The Lancet. Gastroenterology & hepatology
50. Dynamic microbiome and metabolome analyses reveal the interaction between gut microbiota and anti‐PD ‐1 based immunotherapy in hepatocellular carcinoma
    Hewei Wu, Xingrong Zheng, Tao Pan, Xiaoàn Yang, Xiyao Chen, Boxiang Zhang, Liang Peng, Chan Xie · 2022 · International Journal of Cancer
51. Bifidobacterium pseudocatenulatum-Mediated Bile Acid Metabolism to Prevent Rheumatoid Arthritis via the Gut–Joint Axis
    Qing Chun Zhao, Huan Ren, Yang Nian, Xuyang Xia, Qifeng Chen, Dingding Zhou, Zhaoqian Liu, Xiaoping Chen, Yao Chen, Weihua Huang et al. · 2023 · Nutrients
52. Gut microbiota in chronic pain: Novel insights into mechanisms and promising therapeutic strategies
    Liping Liu, Qin Jie Wu, Yuping Chen, Huiling Ren, Qi Zhang, Hengyue Yang, Wenying Zhang, Tingyu Ding, Shujie Wang, Yan Zhang et al. · 2023 · International Immunopharmacology
53. Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer
    Shuyu Liu, Xilan Yang · 2023 · Frontiers in Cellular and Infection Microbiology
54. Role of Gut Microbiota in Breast Cancer and Drug Resistance
    Viswanathan Sathiyapriya, Sheetal Parida, Bhuvana Teja Lingipilli, Krishnan Ramalingam, Devendra Rao Podipireddy, Nethaji Muniraj · 2023 · Pathogens
55. The Role of the Gut Microbiome in Cancer Immunotherapy: Current Knowledge and Future Directions
    Despoina Eugenia Kiousi, Antonia Z. Kouroutzidou, Konstantinos Neanidis, Emmanouil Karavanis, Dimitrios Matthaios, Aglaia Pappa, Αlex Galanis · 2023 · Cancers
56. Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
    Patrick Tiongco Magahis, Steven Brad Maron, Darren Cowzer, Stephanie King, Mark Andrew Schattner, Yelena Yuriy Janjigian, David M. Faleck, Monika Laszkowska · 2023 · Journal for ImmunoTherapy of Cancer
57. Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial
    Serena Porcari, Chiara CICCARESE, Vitor Heidrich, Debora Rondinella, Gianluca Quaranta, Andrea Severino, Daniela Arduini, Sebastiano Buti, Giuseppe Fornarini, Francesca Primi et al. · 2026 · Nature Medicine
58. Disentangling the relationship between tumor genetic programs and immune responsiveness
    Davide Bedognetti, Wouter Hendrickx, Michele Ceccarelli, Lance David Miller, Barbara Seliger · 2016 · Current Opinion in Immunology
59. Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment
    Andrea Botticelli, Ilaria Grazia Zizzari, Federica Mazzuca, Paolo A. Ascierto, Lorenza Putignani, Luca Marchetti, Chiara Napoletano, Marianna Nuti, Paolo Marchetti · 2016 · Oncotarget
60. Gut Microbiota Dynamics during Chemotherapy in Epithelial Ovarian Cancer Patients Are Related to Therapeutic Outcome
    Federica D’Amico, Anna Myriam Perrone, Simone Rampelli, Sara Coluccelli, Monica Barone, Gloria Ravegnini, Marco Fabbrini, Patrizia Brigidi, Pierandrea De Iaco, Silvia Turroni · 2021 · Cancers
61. Microbiota and Colorectal Cancer: From Gut to Bedside
    Miguel G. Silva, Valentina Brunner, Markus Tschurtschenthaler · 2021 · Frontiers in Pharmacology
62. Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice
    Xuhua Duan, Manzhou Wang, Xinwei Han, Jianzhuang Ren, Guo‐Hao Huang, Shuguang Ju, Qinghui Zhang · 2020 · Cell Cycle
63. The critical role of tumor microbiome in cancer immunotherapy
    Liu Yang, Qi Wang, Lijuan He, Xingyu Sun · 2024 · Cancer Biology & Therapy
64. Interactions Between Antidepressants and Intestinal Microbiota
    Feiyu Xu, Qinglian Xie, Weihong Kuang, Zaiquan Dong · 2023 · Neurotherapeutics
65. T helper 17 (Th17) cell responses to the gut microbiota in human diseases
    Chao‐Yue Sun, Na Young Yang, Zuoliang Zheng, Dong Liu, Qi‐Lin Xu · 2023 · Biomedicine & Pharmacotherapy
66. Microbiome bacterial influencers of host immunity and response to immunotherapy
    Yeganeh Yousefi, Kelly J. Baines, Saman Maleki Vareki · 2024 · Cell Reports Medicine
67. Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers
    Chunhao Cao, Siran Yue, Aiping Lü, Chao Liang · 2024 · Pharmacological Research
68. Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities
    Huiyu Wang, Xiaomin Niu, Zhenning Jin, Shaoxing Zhang, Rong Fan, Hua Xiao, Song Hu · 2025 · Journal of Experimental & Clinical Cancer Research
69. The human microbiome in clinical translation: from bench to bedside
    Bautista, Jhommara, Echeverría, Carolina E., Maldonado-Noboa, Iván, Ojeda-Mosquera, Sofía, Hidalgo-Tinoco, Camila, López-Cortés, Andrés · 2025 · Frontiers in Microbiology
70. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity
    Elke Cario · 2016 · Current Opinion in Supportive and Palliative Care
71. Precision medicine for metastatic colorectal cancer: an evolving era
    İrem Güler, Gökçe Aşkan, Jim Klostergaard, İbrahim Halil Şahin · 2019 · Expert Review of Gastroenterology & Hepatology
72. Gut Microbiota Influences Experimental Outcomes in Mouse Models of Colorectal Cancer
    Alyssa A. Leystra, Margie L. Clapper · 2019 · Genes
73. Metabolic regulation in the immune response to cancer
    Qi Wu, Xin Yu, Juanjuan Li, Shengrong Sun, Yi Tu · 2021 · 癌症：英文版
74. Multifaceted modes of action of the anticancer probiotic Enterococcus hirae
    Goubet, Anne-Gaëlle, Wheeler, Richard, Fluckiger, Aurélie, Qu, Bo, Lemaître, Fabien, Iribarren, Kristina, Mondragón, Laura, Tidjani Alou, Maryam, Pizzato, Eugénie, Durand, Sylvère et al. · 2021 · Cell Death & Differentiation
75. The microbiota: An underestimated actor in radiation-induced lesions?
    Sokol, Harry, Adolph, Timon Erik · 2018 · Gut
76. Metabolic regulation on the immune environment of glioma through gut microbiota
    Yingying Lyu, Hui Yang, Chen Liang · 2021 · Seminars in Cancer Biology
77. Gut microbiota modulation: a tool for the management of colorectal cancer
    Yan Wang, Hui Li · 2022 · Journal of Translational Medicine
78. Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
    Concetta Ragone, Carmen Manolio, Angela Mauriello, Beatrice Cavalluzzo, Luigi Buonaguro, Maria Lina Tornesello, Maria Tagliamonte, Luigi Buonaguro · 2022 · Journal of Translational Medicine
79. Microbe-material hybrids for therapeutic applications
    Meng Chen, Lili Xia, Chenyao Wu, Zeyu Wang, Li Sheng Ding, Yujie Xie, Wei Feng, Yu Chen · 2024 · Chemical Society Reviews
80. Immunotherapy Not Working? Check Your Microbiota
    Nathaniel R. West, Fiona M. Powrie · 2015 · Cancer Cell
81. Immune checkpoint inhibitors: a patent review (2010-2015)
    Matthieu Collin · 2016 · Expert Opinion on Therapeutic Patents
82. Role of the Microbiota in Colorectal Cancer: Updates on Microbial Associations and Therapeutic Implications
    Olivia I. Coleman, Tiago Nunes · 2016 · BioResearch open access
83. Tuning cancer fate: the unremitting role of host immunity
    Bianca Calì, Barbara Molon, Antonella Viola · 2017 · Open Biology
84. Immunogenetic Profiling for Gastric Cancers Identifies Sulfated Glycosaminoglycans as Major and Functional B Cell Antigens in Human Malignancies
    Hiroto Katoh, Daisuke Komura, Hiroki Konishi, Ryohei H. Suzuki, Asami Yamamoto, Miwako Kakiuchi, Reiko Sato, Tetsuo Ushiku, Shogo Yamamoto, Kenji Tatsuno et al. · 2017 · Cell Reports
85. Immune Checkpoint Inhibitors in the Treatment of Melanoma: From Basic Science to Clinical Application
    Surface Oncology, 50 Hampshire Street, 8th Floor, Cambridge, MA 02139, USA, Matthew P. Rausch, Karen Taraszka Hastings · 2017 · Codon Publications eBooks
86. Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy
    Wenyu Li, Xiaorong Deng, Tingtao Chen · 2021 · Frontiers in Oncology
87. How microbiota improve immunotherapy
    Ansaldo, Eduard, Belkaid, Yasmine · 2021 · Science
88. Untitled work
    2022 · 10.1016/j.hsr.2021.100010
89. Tumour neoantigen mimicry by microbial species in cancer immunotherapy
    Maximilian Boesch, Florent Baty, Sacha I. Rothschild, M. Tamm, Markus Joerger, Martin Früh, Martin Hugo Brutsche · 2021 · British Journal of Cancer
90. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens
    Yussuf Ali, Ibrahim Inusa, Gaurav V. Sanghvi, Viralkumar B. Mandaliya, Ashok Kumar Bishoyi · 2023 · Microbial Pathogenesis
91. Biofilm and Cancer: Interactions and Future Directions for Cancer Therapy
    Euna Choi, Ben Murray, Sunga Choi · 2023 · International Journal of Molecular Sciences
92. Akkermansia muciniphila: A potential target and pending issues for oncotherapy
    Xu Zhao, Juanjuan Zhao, Dongmei Li, Han Kwang Yang, Chao Chen, Ming Qin, Zhenke Wen, Zhixu He, Lin Xu · 2023 · Pharmacological Research
93. The danger theory of immunity revisited
    Guido Kroemer, Léa Montégut, Oliver Kepp, Laurence Zitvogel · 2024 · Nature reviews. Immunology
94. Hypothesis: stimulation of trained immunity as adjunctive immunotherapy in cancer
    Mihai Gheorghe Netea, Leo A. B. Joosten, Jos W. M. van der Meer · 2017 · Journal of Leukocyte Biology
95. Cancer vaccines: translation from mice to human clinical trials
    Hoyoung M. Maeng, Masaki Terabe, Jay A. Berzofsky · 2018 · Current Opinion in Immunology
96. Diversification and Evolution of Vancomycin-Resistant Enterococcus faecium during Intestinal Domination
    Krista A. Dubin, Deepti Mathur, Peter T. McKenney, Bradford P. Taylor, Eric R. Littmann, Jonathan U. Peled, Marcel R.M. van den Brink, Ying Taur, Eric G. Pamer, João B. Xavier · 2019 · Infection and Immunity
97. Neutrophil–to–lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
    Jhe‐Cyuan Guo, Chia‐Chi Lin, Chen-Yuan Lin, Min‐Shu Hsieh, Hung‐Yang Kuo, Ming-Yu Lien, Yu‐Yun Shao, Ta‐Chen Huang, Chih‐Hung Hsu · 2019 · Anticancer Research
98. Untapped “-omics”: the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment
    Adam S. Komorowski, Rossanna C. Pezo · 2019 · Breast Cancer Research and Treatment
99. Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer
    Carmine Carbone, Geny Piro, Vincenzo Di Noia, Ettore D’Argento, Emanuele Vita, Miriam Grazia Ferrara, Sara Pilotto, Michèle Milella, Giovanni Cammarota, Antonio Gasbarrini et al. · 2019 · Mediators of Inflammation
100. New technologies for developing phage-based tools to manipulate the human microbiome
     Khan Mirzaei, Mohammadali, Deng, Li · 2022 · Trends in Microbiology